FindMyKOL
Clinical trialNCT06805825RecruitingPhase 1Interventional

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

SponsorNovelty Nobility, Inc.Enrollment67Adenoid Cystic CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaGastrointestinal Stromal TumorsNeuroendocrine TumorsSmall-cell Lung Cancer+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This open-label clinical trial will evaluate the safety and tolerability of NN3201 in subjects with advanced and/or metastatic solid tumors known to express c-Kit.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Michigan Hospitals

    Ann Arbor, Michigan, United States

    Recruiting
  • Case Comprehensive Cancer Center

    Cleveland, Ohio, United States

    Recruiting
  • Oregon Health & Science University

    Portland, Oregon, United States

    Recruiting
  • the University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

    Recruiting
  • Next Virginia

    Fairfax, Virginia, United States

    Active, not recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NN3201
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Feb 2025
Primary completion
30 Aug 2027
Completion
31 Dec 2027
Last update posted
23 Sept 2025
Registered enrollment
67
Registry id
NCT06805825
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.